Barclays Maintains Overweight on Marex Group, Raises Price Target to $30
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Benjamin Budish maintains an Overweight rating on Marex Group (NASDAQ:MRX) and raises the price target from $28 to $30.
October 07, 2024 | 6:56 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays has reaffirmed its Overweight rating on Marex Group and increased the price target from $28 to $30, indicating a positive outlook.
The increase in the price target from $28 to $30 by Barclays suggests a positive outlook for Marex Group, likely leading to a short-term price increase. The Overweight rating indicates confidence in the stock's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100